Skip to main content
SpringerLink
Log in

Genetics and Genomics of Stroke

  • Chapter
  • First Online:
Cardiovascular Genetics and Genomics

Abstract

Stroke is defined as the acute onset of focal neurological disturbance arising due to a cerebrovascular cause, confirmed histopathologically or on imaging, where other causes have been excluded. Strokes may either be ischaemic (approximately 80% of cases) or haemorrhagic (20%). Although often thought of as a single disease, stroke represents the end stage of many different pathologies, each of which can result in cerebral ischaemia and/or haemorrhage. Therefore when investigating a stroke patient, investigations are performed to identify the underlying cause. Most cases of ischaemic stroke are caused by one of three pathologies: large vessel atherosclerotic disease (LVD), cerebral small vessel disease (SVD) or cardioembolism, although there are multiple rarer causes including cervical artery dissection. However, even with detailed investigation an underlying cause cannot be found in approximately a quarter of all ischaemic strokes. Haemorrhagic strokes are categorized according to the brain region they arise from; lobar or cortical haemorrhages are commonly caused by cerebral amyloid angiopathy, or an underlying structural lesion for example an arteriovenous malformation. Subcortical haemorrhages are usually associated with hypertension and believed to be often a manifestation of SVD.

This chapter will briefly outline the genetic basis of strokes in general, and highlight key examples of familial forms of stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the twenty-first century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064–89. https://doi.org/10.1161/STR.0b013e318296aeca.

    Article  PubMed  Google Scholar 

  2. Flossmann E, Schulz U, Rothwell P. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke. 2004;35:212–27. https://doi.org/10.1161/01.STR.0000107187.84390.AA.

    Article  PubMed  Google Scholar 

  3. Meschia JF. Ischaemic stroke: one or several complex genetic disorders? Lancet Neurol. 2003;2:459.

    Article  PubMed  Google Scholar 

  4. Rubattu S, Volpe M, Kreutz R, et al. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet. 1996;13:429–34. https://doi.org/10.1038/ng0896-429.

    Article  CAS  PubMed  Google Scholar 

  5. Bak S, Gaist D, Sindrup SH, et al. Genetic liability in stroke: a long-term follow-up study of Danish twins. Stroke. 2002;33:769–74.

    Article  PubMed  Google Scholar 

  6. Brass LM, Isaacsohn JL, Merikangas KR, Robinette CD. A study of twins and stroke. Stroke. 1992;23:221–3.

    Article  CAS  PubMed  Google Scholar 

  7. Kiely DK, P A W, L A C, et al. Familial aggregation of stroke. The Framingham Study. Stroke. 1993;24:1366–71. https://doi.org/10.1161/01.STR.24.9.1366.

    Article  CAS  PubMed  Google Scholar 

  8. Bevan S, Traylor M, Adib-Samii P, et al. Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke. 2012;43:3161–7. https://doi.org/10.1161/STROKEAHA.112.665760.

    Article  CAS  PubMed  Google Scholar 

  9. Traylor M, Malik R, Nalls MA, et al. Genetic variation at 16q24.2 is associated with small vessel stroke. Ann Neurol. 2016;81(3):383–94. https://doi.org/10.1002/ana.24840.

    Article  CAS  Google Scholar 

  10. Bellenguez C, Bevan S, Gschwendtner A, et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet. 2012;44:328–33. https://doi.org/10.1038/ng.1081.

    Article  CAS  PubMed  Google Scholar 

  11. Traylor M, Farrall M, Holliday EG, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11:951–62. https://doi.org/10.1016/S1474-4422(12)70234-X.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium, Stroke Genetics Network (SiGN), International Stroke Genetics Consortium (ISGC). Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2016;15:695–707. https://doi.org/10.1016/S1474-4422(16)00102-2.

    Article  Google Scholar 

  13. Traylor M, Mäkelä K-M, Kilarski LL, et al. A novel MMP12 locus is associated with large artery atherosclerotic stroke using a genome-wide age-at-onset informed approach. PLoS Genet. 2014;10:e1004469. https://doi.org/10.1371/journal.pgen.1004469.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Woo D, Falcone GJ, Devan WJ, et al. Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. Am J Hum Genet. 2014;94:511–21. https://doi.org/10.1016/j.ajhg.2014.02.012.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Tan RYY, Markus HS. Monogenic causes of stroke: now and the future. J Neurol. 2015;262(12):2601–16. https://doi.org/10.1007/s00415-015-7794-4.

    Article  PubMed  Google Scholar 

  16. Joutel A, Haddad I, Ratelade J, Nelson MT. Perturbations of the cerebrovascular matrisome: a convergent mechanism in small vessel disease of the brain? J Cereb Blood Flow Metab. 2016;36:143–57. https://doi.org/10.1038/jcbfm.2015.62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Tan RYY, Traylor M, Rutten-Jacobs L, Markus HS. New insights into mechanisms of small vessel disease stroke from genetics. Clin Sci. 2017;131(7):515–31.

    Article  CAS  PubMed  Google Scholar 

  18. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707–10. https://doi.org/10.1038/383707a0.

    Article  CAS  PubMed  Google Scholar 

  19. Fukutake T. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification. J Stroke Cerebrovasc Dis. 2011;20:85–93. https://doi.org/10.1016/j.jstrokecerebrovasdis.2010.11.008.

    Article  PubMed  Google Scholar 

  20. Verdura E, Hervé D, Scharrer E, et al. Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease. Brain. 2015;138(Pt 8):2347–58. https://doi.org/10.1093/brain/awv155.

    Article  PubMed  Google Scholar 

  21. Nozaki H, Kato T, Nihonmatsu M, et al. Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL. Neurology. 2016;86:1964–74. https://doi.org/10.1212/WNL.0000000000002694.

    Article  CAS  PubMed  Google Scholar 

  22. Bugiani M, Kevelam SH, Bakels HS, et al. Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). Neurology. 2016;87(17):1777–86. https://doi.org/10.1212/WNL.0000000000003251.

    Article  CAS  PubMed  Google Scholar 

  23. DiFrancesco JC, Novara F, Zuffardi O, et al. TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy. Neurol Sci. 2014;36(2):323–30. https://doi.org/10.1007/s10072-014-1944-9.

    Article  PubMed  Google Scholar 

  24. French CR, Seshadri S, Destefano AL, et al. Mutation of FOXC1 and PITX2 induces cerebral small-vessel disease. J Clin Invest. 2014;124:4877–81. https://doi.org/10.1172/JCI75109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911–20. https://doi.org/10.1056/NEJMoa1307361.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Jenkinson EM, Rodero MP, Kasher PR, et al. Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts. Nat Genet. 2016;48(10):1185–92. https://doi.org/10.1038/ng.3661.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mitsias P, Levine SR. Cerebrovascular complications of Fabry’s disease. Ann Neurol. 1996;40:8–17. https://doi.org/10.1002/ana.410400105.

    Article  CAS  PubMed  Google Scholar 

  28. Chassaing N, Martin L, Calvas P, et al. Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet. 2005;42:881–92. https://doi.org/10.1136/jmg.2004.030171.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Gutmann DH, Ferner RE, Listernick RH, et al. Neurofibromatosis type 1. Nat Rev. Dis Prim. 2017;3:17004. https://doi.org/10.1038/nrdp.2017.4.

    Article  PubMed  Google Scholar 

  30. Buoni S, Molinelli M, Mariottini A, et al. Homocystinuria with transverse sinus thrombosis. J Child Neurol. 2001;16:688–90. https://doi.org/10.1177/088307380101600913.

    Article  CAS  PubMed  Google Scholar 

  31. Renard D, Miné M, Pipiras E, et al. Cerebral small-vessel disease associated with COL4A1 and COL4A2 gene duplications. Neurology. 2014;83:1029–31. https://doi.org/10.1212/WNL.0000000000000769.

    Article  PubMed  Google Scholar 

  32. Revesz T, Holton JL, Lashley T, et al. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol. 2009;118:115–30. https://doi.org/10.1007/s00401-009-0501-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Vidal R, Frangione B, Rostagno A, et al. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature. 1999;399:776–81. https://doi.org/10.1038/21637.

    Article  CAS  PubMed  Google Scholar 

  34. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet. 2009;17:860–71. https://doi.org/10.1038/ejhg.2009.35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Perrone RD, Malek AM, Watnick T. Vascular complications in autosomal dominant polycystic kidney disease. Nat Rev. Nephrol. 2015;11:589–98. https://doi.org/10.1038/nrneph.2015.128.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Fischer A, Zalvide J, Faurobert E, et al. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol Med. 2013;19:302–8. https://doi.org/10.1016/j.molmed.2013.02.004.

    Article  CAS  PubMed  Google Scholar 

  37. Weitz NA, Lauren CT, Behr GG, et al. Clinical spectrum of capillary malformation-arteriovenous malformation syndrome presenting to a pediatric dermatology practice: a retrospective study. Pediatr Dermatol. 2015;32:76–84. https://doi.org/10.1111/pde.12384.

    Article  PubMed  Google Scholar 

  38. O’Sullivan M, Jarosz JM, Martin RJ, et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56:628–34.

    Article  PubMed  Google Scholar 

  39. Bellingham AJ. The sickling process in relation to clinical manifestations. J Clin Pathol. 1974;8:23–5.

    Article  CAS  Google Scholar 

  40. Allison AC. Protection afforded by sickle-cell trait against subtertian malarial infection. BMJ. 1954;1:290–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Bender M, Douthitt Seibel G. Sickle cell disease. 1993. https://www.ncbi.nlm.nih.gov/books/NBK1377/.

  42. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288–94.

    CAS  PubMed  Google Scholar 

  43. Gemmete JJ, Davagnanam I, Toma AK, et al. Arterial ischemic stroke in children. Neuroimaging Clin N Am. 2013;23:781–98. https://doi.org/10.1016/j.nic.2013.03.019.

    Article  PubMed  Google Scholar 

  44. Strouse JJ, Jordan LC, Lanzkron S, Casella JF. The excess burden of stroke in hospitalized adults with sickle cell disease. Am J Hematol. 2009;84:548–52. https://doi.org/10.1002/ajh.21476.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Kirkham FJ. Therapy Insight: stroke risk and its management in patients with sickle cell disease. Nat Clin Pract Neurol. 2007;3:264–78. https://doi.org/10.1038/ncpneuro0495.

    Article  CAS  PubMed  Google Scholar 

  46. Lawrence C, Webb J. Sickle cell disease and stroke: diagnosis and management. Curr Neurol Neurosci Rep. 2016;16:27. https://doi.org/10.1007/s11910-016-0622-0.

    Article  PubMed  Google Scholar 

  47. Schnog JB, Mac Gillavry MR, van Zanten AP, et al. Protein C and S and inflammation in sickle cell disease. Am J Hematol. 2004;76:26–32. https://doi.org/10.1002/ajh.20052.

    Article  CAS  PubMed  Google Scholar 

  48. Yasin Z, Witting S, Palascak MB, et al. Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F. Blood. 2003;102:365–70. https://doi.org/10.1182/blood-2002-11-3416.

    Article  CAS  PubMed  Google Scholar 

  49. Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 2006;5:501–12. https://doi.org/10.1016/S1474-4422(06)70469-0.

    Article  PubMed  Google Scholar 

  50. Francis RB, Haywood LJ. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J Natl Med Assoc. 1992;84:611–5.

    PubMed  PubMed Central  Google Scholar 

  51. Hines PC, McKnight TP, Seto W, et al. Central nervous system events in children with sickle cell disease presenting acutely with headache. J Pediatr. 2011;159:472–8. https://doi.org/10.1016/j.jpeds.2011.02.009.

    Article  PubMed  Google Scholar 

  52. Seeler RA, Royal JE, Powe L, Goldberg HR. Moyamoya in children with sickle cell anemia and cerebrovascular occlusion. J Pediatr. 1978;93:808–10.

    Article  CAS  PubMed  Google Scholar 

  53. Powars D, Adams RJ, Nichols FT, et al. Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia. J Assoc Acad Minor Phys. 1990;1:79–82.

    CAS  PubMed  Google Scholar 

  54. Powars D, Wilson B, Imbus C, et al. The natural history of stroke in sickle cell disease. Am J Med. 1978;65:461–71.

    Article  CAS  PubMed  Google Scholar 

  55. Oyesiku NM, Barrow DL, Eckman JR, et al. Intracranial aneurysms in sickle-cell anemia: clinical features and pathogenesis. J Neurosurg. 1991;75:356–63. https://doi.org/10.3171/jns.1991.75.3.0356.

    Article  CAS  PubMed  Google Scholar 

  56. Armstrong FD, Thompson RJ, Wang W, et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics. 1996;97:864–70.

    CAS  PubMed  Google Scholar 

  57. Miller ST, Macklin EA, Pegelow CH, et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the cooperative study of sickle cell disease. J Pediatr. 2001;139:385–90. https://doi.org/10.1067/mpd.2001.117580.

    Article  CAS  PubMed  Google Scholar 

  58. Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326:605–10. https://doi.org/10.1056/NEJM199202273260905.

    Article  CAS  PubMed  Google Scholar 

  59. Driscoll MC, Hurlet A, Styles L, et al. Stroke risk in siblings with sickle cell anemia. Blood. 2003;101:2401–4.

    Article  CAS  PubMed  Google Scholar 

  60. Sampaio Silva G, Vicari P, Figueiredo MS, et al. Transcranial doppler in adult patients with sickle cell disease. Cerebrovasc Dis. 2006;21:38–41. https://doi.org/10.1159/000089592.

    Article  PubMed  Google Scholar 

  61. Flanagan JM, Frohlich DM, Howard TA, et al. Genetic predictors for stroke in children with sickle cell anemia. Blood. 2011;117:6681–4. https://doi.org/10.1182/blood-2011-01-332205.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Lettre G, Sankaran VG, Bezerra MAC, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci. 2008;105:11869–74. https://doi.org/10.1073/pnas.0804799105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Hoppe C, Klitz W, Cheng S, et al. Gene interactions and stroke risk in children with sickle cell anemia. Blood. 2004;103:2391–6. https://doi.org/10.1182/blood-2003-09-3015.

    Article  CAS  PubMed  Google Scholar 

  64. Sebastiani P, Ramoni MF, Nolan V, et al. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet. 2005;37:435–40. https://doi.org/10.1038/ng1533.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. JGT VI, Tang DC, Savage SA, et al. Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood. 2002;100:4303–9. https://doi.org/10.1182/blood-2001-12-0306.

    Article  CAS  Google Scholar 

  66. Hoppe C, Klitz W, Noble J, et al. Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood. 2003;101:2865–9. https://doi.org/10.1182/blood-2002-09-2791.

    Article  CAS  PubMed  Google Scholar 

  67. Flanagan JM, Sheehan V, Linder H, et al. Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood. 2013;121:3237–45. https://doi.org/10.1182/blood-2012-10-464156.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Geard A, Pule GD, Chelo D, et al. Genetics of sickle cell-associated cardiovascular disease: an expert review with lessons learned in Africa. Omi A J Integr Biol. 2016;20:581–92. https://doi.org/10.1089/omi.2016.0125.

    Article  CAS  Google Scholar 

  69. Johnson CS. Arterial blood pressure and hyperviscosity in sickle cell disease. Hematol Oncol Clin North Am. 2005;19:827–37. https://doi.org/10.1016/j.hoc.2005.08.006.

    Article  PubMed  Google Scholar 

  70. Estcourt LJ, Fortin PM, Hopewell S, et al. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. Cochrane Database Syst Rev. 2017;11:CD003146.

    Google Scholar 

  71. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med. 1998;339:5–11. https://doi.org/10.1056/NEJM199807023390102.

    Article  CAS  PubMed  Google Scholar 

  72. Investigators TOPSP in SCA (STOP 2) T. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353:2769–78. https://doi.org/10.1056/NEJMoa050460.

    Article  Google Scholar 

  73. Razvi SSM, Davidson R, Bone I, Muir KW. The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry. 2005;76:739–41. https://doi.org/10.1136/jnnp.2004.051847.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Narayan SK, Gorman G, Kalaria RN, et al. The minimum prevalence of CADASIL in northeast England. Neurology. 2012;78:1025–7. https://doi.org/10.1212/WNL.0b013e31824d586c.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Kilarski LL, Rutten-Jacobs LCA, Bevan S, et al. Prevalence of CADASIL and Fabry disease in a Cohort of MRI defined younger onset lacunar stroke. PLoS One. 2015;10:e0136352. https://doi.org/10.1371/journal.pone.0136352.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  76. Tan RYY, Markus HS. CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships. PLoS One. 2016;11:e0157613. https://doi.org/10.1371/journal.pone.0157613.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Adib-Samii P, Brice G, Martin RJ, Markus HS. Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke. 2010;41(4):630. https://doi.org/10.1161/STROKEAHA.109.568402.

    Article  PubMed  Google Scholar 

  78. Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511–5. https://doi.org/10.1016/S0140-6736(97)08083-5.

    Article  CAS  PubMed  Google Scholar 

  79. Singhal S, Bevan S, Barrick T, et al. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain. 2004;127:2031–8. https://doi.org/10.1093/brain/awh223.

    Article  PubMed  Google Scholar 

  80. Opherk C, Peters N, Holtmannspötter M, et al. Heritability of MRI lesion volume in CADASIL: evidence for genetic modifiers. Stroke. 2006;37:2684–9. https://doi.org/10.1161/01.STR.0000245084.35575.66.

    Article  PubMed  Google Scholar 

  81. Peters N, Holtmannspotter M, Opherk C, et al. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology. 2006;66:1517–22. https://doi.org/10.1212/01.wnl.0000216271.96364.50.

    Article  CAS  PubMed  Google Scholar 

  82. Singhal S, Rich P, Markus HS. The spatial distribution of MR imaging abnormalities in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and their relationship to age and clinical features. AJNR Am J Neuroradiol. 2005;26:2481–7.

    PubMed  Google Scholar 

  83. Investigators TS. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012;367:817–25. https://doi.org/10.1056/NEJMoa1204133.

    Article  CAS  Google Scholar 

  84. Donnini I, Nannucci S, Valenti R, et al. Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience. J Headache Pain. 2012;13:299–302. https://doi.org/10.1007/s10194-012-0426-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Forteza AM, Brozman B, Rabinstein AA, et al. Acetazolamide for the treatment of migraine with aura in CADASIL. Neurology. 2001;57:2144–5. https://doi.org/10.1212/WNL.57.11.2144.

    Article  CAS  PubMed  Google Scholar 

  86. Weller M, Dichgans J, Klockgether T. Acetazolamide-responsive migraine in CADASIL. Neurology. 1998;50:1505. https://doi.org/10.1212/WNL.50.5.1505.

    Article  CAS  PubMed  Google Scholar 

  87. Martikainen MH, Roine S. Rapid improvement of a complex migrainous episode with sodium valproate in a patient with CADASIL. J Headache Pain. 2012;13:95–7. https://doi.org/10.1007/s10194-011-0400-y.

    Article  PubMed  Google Scholar 

  88. MHRA. Imigran 100 mg tablets (sumatriptan succinate) patient information leaflet. In: Medical information and production details. 2013. http://www.medicines.org.uk/emc/medicine/749. Accessed 27 Sept 2015.

  89. Schon F, Martin RJ, Prevett M, et al. “CADASIL coma”: an underdiagnosed acute encephalopathy. J Neurol Neurosurg Psychiatry. 2003;74:249–52. https://doi.org/10.1136/jnnp.74.2.249.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Zheng DM, FF X, Gao Y, et al. A Chinese pedigree of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): clinical and radiological features. J Clin Neurosci. 2009;16:847–9. https://doi.org/10.1016/j.jocn.2008.08.031.

    Article  CAS  PubMed  Google Scholar 

  91. Mendioroz M, Fernández-Cadenas I, Del Río-Espinola A, et al. A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population. Neurology. 2010;75:2033–5. https://doi.org/10.1212/WNL.0b013e3181ff96ac.

    Article  CAS  PubMed  Google Scholar 

  92. Nozaki H, Sekine Y, Fukutake T, et al. Characteristic features and progression of abnormalities on MRI for CARASIL. Neurology. 2015;85:459–63. https://doi.org/10.1212/WNL.0000000000001803.

    Article  CAS  PubMed  Google Scholar 

  93. Yanagawa S, Ito N, Arima K, Ikeda S -i S. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neurology. 2002;58:817–20. https://doi.org/10.1212/WNL.58.5.817.

    Article  PubMed  Google Scholar 

  94. Oka C, Tsujimoto R, Kajikawa M, et al. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development. 2004;131:1041–53. https://doi.org/10.1242/dev.00999.

    Article  CAS  PubMed  Google Scholar 

  95. Chen Y, He Z, Meng S, et al. A novel mutation of the high-temperature requirement A serine peptidase 1 (HTRA1) gene in a Chinese family with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). J Int Med Res. 2013;41:1445–55. https://doi.org/10.1177/0300060513480926.

    Article  PubMed  CAS  Google Scholar 

  96. Gunda B, Mine M, Kovács T, et al. COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy. J Neurol. 2014;261(3):500. https://doi.org/10.1007/s00415-013-7224-4.

    Article  PubMed  Google Scholar 

  97. Breedveld G, de Coo IF, Lequin MH, et al. Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly. J Med Genet. 2006;43:490–5. https://doi.org/10.1136/jmg.2005.035584.

    Article  CAS  PubMed  Google Scholar 

  98. Alamowitch S, Plaisier E, Favrole P, et al. Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome. Neurology. 2009;73:1873–82. https://doi.org/10.1212/WNL.0b013e3181c3fd12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Jeanne M, Labelle-Dumais C, Jorgensen J, et al. COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet. 2012;90:91–101. https://doi.org/10.1016/j.ajhg.2011.11.022.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Plaisier E, Gribouval O, Alamowitch S, et al. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med. 2007;357:2687–95. https://doi.org/10.1056/NEJMoa071906.

    Article  CAS  PubMed  Google Scholar 

  101. Rannikmäe K, Davies G, Thomson PA, et al. Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease. Neurology. 2015;84(9):918–26. https://doi.org/10.1212/WNL.0000000000001309.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  102. Linn J, Halpin A, Demaerel P, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology. 2010;74:1346–50. https://doi.org/10.1212/WNL.0b013e3181dad605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke. 1987;18:311–24.

    Article  CAS  PubMed  Google Scholar 

  104. Thanprasertsuk S, Martinez-Ramirez S, Pontes-Neto OM, et al. Posterior white matter disease distribution as a predictor of amyloid angiopathy. Neurology. 2014;83:794–800. https://doi.org/10.1212/WNL.0000000000000732.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stroke Research Group, Department of Clinical Neurosciences, Cambridge Biomedical Campus, Cambridge, UK

    Rhea Y. Y. Tan & Hugh S. Markus

Authors
  1. Rhea Y. Y. Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hugh S. Markus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hugh S. Markus .

Editor information

Editors and Affiliations

  1. Institute of Cancer & Genetics, University Hospital of Wales, Cardiff, United Kingdom

    Dhavendra Kumar

  2. Barts Heart Centre, St Bartholomew’s Hospital, London, United Kingdom

    Perry Elliott

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tan, R.Y.Y., Markus, H.S. (2018). Genetics and Genomics of Stroke. In: Kumar, D., Elliott, P. (eds) Cardiovascular Genetics and Genomics. Springer, Cham. https://doi.org/10.1007/978-3-319-66114-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66114-8_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66112-4

  • Online ISBN: 978-3-319-66114-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation